IntroductionIn February 2022, BlackBasta emerged as a successor to Conti ransomware and quickly rose to prominence. BlackBasta was operational for three years until February 2025 when their internal ...
Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research (AACR) Annual ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...
Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise ...
UK based provider of physical layer IP for 5G non-terrestrial networks (NTN), AccelerComm Ltd, today announced the grant of its 56th international patent, marking a significant milestone as the ...
Whether estimating the probability that a disease is present or forecasting risk of deterioration,1 readmission,2 or death,3 most contemporary clinical artificial intelligence (AI) systems are ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
This study presents valuable findings by reanalyzing previously published MEG and ECoG datasets to challenge the predictive nature of pre-onset neural encoding effects. The evidence supporting the ...
The rise of Africa’s AI factoriesUnpacking the global intelligence infrastructure revolution − and what it means for South Africa. By Eugene Perumal, Eugene Perumal, founder and principal of ...
The world’s most consequential technology organisations are no longer building software only − they are building factories.
Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...